[go: up one dir, main page]

MX2009009931A - Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea. - Google Patents

Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.

Info

Publication number
MX2009009931A
MX2009009931A MX2009009931A MX2009009931A MX2009009931A MX 2009009931 A MX2009009931 A MX 2009009931A MX 2009009931 A MX2009009931 A MX 2009009931A MX 2009009931 A MX2009009931 A MX 2009009931A MX 2009009931 A MX2009009931 A MX 2009009931A
Authority
MX
Mexico
Prior art keywords
allergy
probiotics
caesarean section
reduce development
infants born
Prior art date
Application number
MX2009009931A
Other languages
English (en)
Inventor
Norbert Sprenger
Marie-Claire Fichot
Karl-Josef Huber-Haag
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2009009931A publication Critical patent/MX2009009931A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe el uso de bacterias probióticas en la elaboración de un medicamento o composición nutricional terapéutica para reducir el riesgo de desarrollo subsecuente de alergia en lactantes quienes nacieron por cesárea.
MX2009009931A 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea. MX2009009931A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07105074A EP1974743A1 (en) 2007-03-28 2007-03-28 Probiotics to Improve Gut Microbiota
PCT/EP2008/053644 WO2008116907A1 (en) 2007-03-28 2008-03-27 Probiotics to reduce development of allergy in infants born by caesarean section

Publications (1)

Publication Number Publication Date
MX2009009931A true MX2009009931A (es) 2009-09-24

Family

ID=38051788

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.
MX2009009931A MX2009009931A (es) 2007-03-28 2008-03-27 Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
MX2009009318A MX2009009318A (es) 2007-03-28 2008-03-27 Probioticos para reducir los episodios de diarrea en bebes nacidos por operacion cesarea.
MX2009010252A MX337667B (es) 2007-03-28 2008-03-27 Combinacion simbiotica para mejorar la microbiota intestinal.
MX2009009442A MX2009009442A (es) 2007-03-28 2008-03-27 Probioticos para mejorar la microbiota intestinal.

Country Status (15)

Country Link
US (4) US20100119488A1 (es)
EP (6) EP1974743A1 (es)
CN (4) CN101646453A (es)
AU (4) AU2008231775A1 (es)
BR (4) BRPI0809355A2 (es)
CA (4) CA2682654A1 (es)
ES (2) ES2434566T3 (es)
MX (4) MX2009009318A (es)
MY (1) MY151137A (es)
PL (2) PL2131680T3 (es)
PT (2) PT2131680E (es)
RU (4) RU2456008C2 (es)
UA (2) UA97662C2 (es)
WO (4) WO2008116892A1 (es)
ZA (3) ZA200907538B (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
AU2007222598B2 (en) * 2006-03-07 2013-01-10 Société des Produits Nestlé S.A. Synbiotic mixture
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
MX2011005490A (es) * 2008-12-05 2011-06-20 Nestec Sa Composiciones para usarse en niños con peso de nacimiento bajo.
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
WO2010103132A1 (es) * 2009-03-10 2010-09-16 Hero España, S.A. Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
WO2016026684A1 (en) 2014-08-18 2016-02-25 Nestec S.A. Prebiotics for reducing the risk of obesity later in life
RU2012107695A (ru) * 2009-07-31 2013-09-10 Нестек С.А. Питательная композиция для вскармливаемых грудью детей или домашних животных с пробиотиками и подобранными питательными веществами
EP2289527B1 (en) * 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
BR112013017023A2 (pt) * 2010-12-29 2019-09-24 Nestec Sa fibra e probióticos para a redução dos sintomas instestinais relacionados com o estresse
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
DK3366143T3 (da) 2011-06-20 2025-01-27 Heinz Co Brands H J Llc Probiotiske sammensætninger og fremgangsmåder
JP5877902B2 (ja) 2011-08-17 2016-03-08 マイクロバイオーム セラピューティクス，エルエルシー バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用
BR112014007829A2 (pt) * 2011-10-18 2017-04-18 Nestec Sa composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio
EP3978598B1 (en) 2011-12-01 2024-08-28 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
JP6115094B2 (ja) * 2012-11-15 2017-04-19 株式会社Ｇｓユアサ 蓄電素子及び蓄電素子の製造方法
PL3470074T3 (pl) 2013-05-10 2021-04-06 H.J. Heinz Company Brands Llc Probiotyki
US10758555B2 (en) 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
ES2916813T3 (es) * 2013-11-15 2022-07-06 Nestle Sa Composiciones para uso en la prevención o tratamiento de enterocolitis necrotizante en lactantes y niños pequeños
US10940158B2 (en) 2013-11-15 2021-03-09 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
AU2014350157A1 (en) * 2013-11-15 2016-04-14 Nestec S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
EP3212208B1 (en) * 2014-10-29 2021-03-03 Biogaia AB Use of l. reuteri for prevention or treatment of microbiota dysbiosis in early life
WO2016183535A1 (en) * 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
MX385648B (es) * 2015-08-04 2025-03-18 Soc Des Produits Nestle S A Star Composiciones nutritivas y formulas infantiles que comprenden bifidobacterium animalis ssp.lactis y, opcionalmente, una mezcla de oligosacaridos para inducir una microbiota intestinal cercana a la de un infante alimentado por lactancia materna.
WO2017043963A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Kit of parts for stimulating microbiota health after non-natural birth
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
CN108495562A (zh) * 2016-01-26 2018-09-04 雀巢产品技术援助有限公司 具有特异性低聚糖的用于预防或治疗变态反应的组合物
EP3466435B1 (en) * 2016-05-31 2023-08-16 Morinaga Milk Industry Co., Ltd. Brain function improving agent
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
WO2018024440A1 (en) * 2016-08-04 2018-02-08 Nestec Sa Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
WO2018202657A1 (en) * 2017-05-05 2018-11-08 Nestec S.A. Treatment of infant colic
EP3661371A1 (en) * 2017-08-04 2020-06-10 Société des Produits Nestlé S.A. Probiotic bacteria preconditioned in a gos-containing medium and use thereof
CN113164532A (zh) * 2018-05-30 2021-07-23 进化生物系统股份有限公司 H5功能性长双歧杆菌婴儿亚种的组合物和使用方法
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN109497271A (zh) * 2018-12-06 2019-03-22 江苏奥迈生物科技有限公司 一种提高断奶仔猪免疫力的复合饲料添加剂及其制备方法
US20220293275A1 (en) * 2019-06-11 2022-09-15 CJ Bioscience. Inc Method for detecting gut dysbiosis of infant
TWI754302B (zh) * 2019-06-21 2022-02-01 大江生醫股份有限公司 乳雙歧桿菌tci604及其代謝產物的應用
CN111053244A (zh) * 2019-12-06 2020-04-24 山东体育学院 一种基于肠道微生物的营养调节方法及系统
CN111296711A (zh) * 2020-03-31 2020-06-19 广州纽缤乐营养科技股份有限公司 一种益生菌固体饮料及其制备方法
EP4180880A1 (fr) * 2021-11-10 2023-05-17 Montres Breguet S.A. Dispositif d'affichage d'une succession d'indications d'une grandeur temporelle pour une pièce d'horlogerie
WO2023237687A1 (en) * 2022-06-10 2023-12-14 Dsm Ip Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
EP4536010A1 (en) * 2022-06-10 2025-04-16 DSM IP Assets B.V. Combinations comprising vitamin b2 and lactobacillus rhamnosus
KR20250117389A (ko) 2022-11-17 2025-08-04 엥스티튀 나쇼날 드 르쉐르슈 푸흐 라그리컬튀흐, 랄리망따씨옹 에 랑비허른망 리모실락토바실루스 무코사에 및 glp-1 증가가 필요한 장애
WO2024160209A1 (zh) * 2023-02-01 2024-08-08 北京三元食品股份有限公司 一株母乳来源的鼠李糖乳酪杆菌及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SU1743607A1 (ru) * 1990-02-05 1992-06-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ профилактики дисбактериоза кишечника у новорожденных детей
EP0577903B1 (fr) 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
DK0577904T3 (da) 1992-07-06 1997-10-27 Nestle Sa Mælkesyrebakterie.
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
DE19958985A1 (de) * 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP1646589A1 (en) 2003-06-27 2006-04-19 Bio-Circuit ApS A biogas producing facility with anaerobic hydrolysis
EP1926395A1 (en) * 2005-04-13 2008-06-04 Nestec S.A. Infant formula with probiotics
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
ES2342625T5 (es) 2006-02-10 2020-05-07 Nestle Sa Mezcla de oligosacáridos
AU2007222598B2 (en) * 2006-03-07 2013-01-10 Société des Produits Nestlé S.A. Synbiotic mixture
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains

Also Published As

Publication number Publication date
BRPI0809355A2 (pt) 2014-09-02
BRPI0809626A2 (pt) 2014-09-23
CN101646453A (zh) 2010-02-10
MX337667B (es) 2016-03-14
EP2489280A3 (en) 2013-06-26
RU2521500C2 (ru) 2014-06-27
US20100119488A1 (en) 2010-05-13
RU2009139660A (ru) 2011-05-10
ZA200907538B (en) 2011-04-28
WO2008116916A1 (en) 2008-10-02
PT2131680E (pt) 2013-10-28
EP1974743A1 (en) 2008-10-01
US20100086527A1 (en) 2010-04-08
CA2679081A1 (en) 2008-10-02
EP2129393A1 (en) 2009-12-09
MY151137A (en) 2014-04-30
US20100150874A1 (en) 2010-06-17
ZA200907541B (en) 2011-04-28
RU2009139667A (ru) 2011-05-10
AU2008231702A1 (en) 2008-10-02
EP2131680A1 (en) 2009-12-16
ES2434566T3 (es) 2013-12-16
EP2131859B1 (en) 2016-04-27
AU2008231763B2 (en) 2013-10-31
WO2008116907A1 (en) 2008-10-02
RU2456008C2 (ru) 2012-07-20
EP2489280A2 (en) 2012-08-22
EP2129242A1 (en) 2009-12-09
AU2008231775A1 (en) 2008-10-02
BRPI0809622A2 (pt) 2014-09-16
UA97663C2 (ru) 2012-03-12
CA2678994A1 (en) 2008-03-27
MX2009010252A (es) 2009-10-13
PL2131680T3 (pl) 2014-01-31
CA2680093A1 (en) 2008-10-02
US20100119497A1 (en) 2010-05-13
CA2682654A1 (en) 2008-10-02
UA97662C2 (ru) 2012-03-12
CN101646452A (zh) 2010-02-10
BRPI0809356A2 (pt) 2014-09-02
EP2131859A1 (en) 2009-12-16
CN101652080A (zh) 2010-02-17
RU2009139669A (ru) 2011-05-10
AU2008231778A1 (en) 2008-10-02
WO2008116904A1 (en) 2008-10-02
PL2131859T3 (pl) 2016-12-30
RU2009139658A (ru) 2011-05-10
CN101652079A (zh) 2010-02-17
ZA200907731B (en) 2011-04-28
PT2131859T (pt) 2016-07-13
ES2577434T3 (es) 2016-07-14
WO2008116892A1 (en) 2008-10-02
EP2131680B1 (en) 2013-08-14
AU2008231702B2 (en) 2014-01-16
MX2009009442A (es) 2009-09-14
AU2008231763A1 (en) 2008-10-02
MX2009009318A (es) 2009-09-10

Similar Documents

Publication Publication Date Title
MX2009009931A (es) Probioticos para reducir el desarrollo de alergia en lactantes nacidos por cesarea.
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
PH12014501749A1 (en) A nutritional composition comprising probiotics and improving sleep patterns
MY158816A (en) Probiotics for reduction of risk of obesity
TW201711676A (en) Ferric citrate dosage forms
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
MX2010005132A (es) Uso de oligosacaridos conteniendo n-acetilactosamina para maduración de las respuestas inmunes en neonatos.
MY164356A (en) Substituted 5-fluoro-1h-pyrazolopyridines and their use
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
PT2510916T (pt) Composição farmacêutica antisséptica para a higiene oral e o tratamento de doenças bucais de origem microbiana
IN2012DN00791A (es)
MX2009009670A (es) Reduccion de riesgo de diarrea.
MY150931A (en) Substituted oxazolidinones and their use
IL194353A0 (en) Lysobactin amides
MX2009011214A (es) Uso de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)- 5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.
UA41936U (ru) Способ лечения крауроза вульвы в детском возрасте
UA53217U (en) Mask for therapy and general health improvement
UA96804C2 (uk) Лікарський препарат, що включає порошок белемніту
UA37658U (en) Device for thoracocentesis
UA60203U (ru) Способ профилактики заболеваний желудочно-кишечного тракта у новорожденных телят
UA34798U (ru) Способ коррекции состояния макрофагальной фагоцитирующей системы у больных с соматоформными депрессивными расстройствами
UA93309C2 (ru) Способ получения препарата для профилактики moho- и полигипомикроэлементозов у вольных свиноматок

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal